Literature DB >> 10233756

Epitope mapping of 10 monoclonal antibodies against the pig analogue of human membrane cofactor protein (MCP).

J M Pérez De La Lastra1, C W Van Den Berg, R Bullido, F Almazán, J Domínguez, D Llanes, B P Morgan.   

Abstract

Pig membrane cofactor protein (MCP; CD46) is a 50 000-60 000 MW glycoprotein that is expressed on a wide variety of cells, including erythrocytes. Pig MCP has cofactor activity for factor I-mediated cleavage of C3b and is an efficient regulator of the classical and alternative pathway of human and pig complement. A panel of 10 monoclonal antibodies (mAbs) was collected from two different laboratories; all of these mAbs were raised against pig leucocytes and all recognized the same complex banding pattern on sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) of erythrocyte membranes. All were shown to be reactive with pig MCP and were divided into four groups of mutually competitive antibodies based on competition studies for membrane-bound MCP and for soluble MCP, the latter by surface plasmon resonance (SPR) analysis. The antigenic properties of membrane-bound and soluble MCP were similar, although some interesting differences were revealed. None of the 10 mAbs were cross-reactive with human MCP and only one showed cross-reactivity with leucocytes from a panel of large mammals - a weak cross-reactivity with a subset of dog leucocytes. All antibodies in one of the epitope groups and some in a second epitope group were able to block the functional activity of pig MCP, as measured by inhibition of MCP-catalysed C3 degradation by factor I.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233756      PMCID: PMC2326796          DOI: 10.1046/j.1365-2567.1999.00732.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

Review 1.  Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster.

Authors:  M K Liszewski; T W Post; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  Analysis of monoclonal antibodies reactive with the porcine CD2 antigen.

Authors:  M D Pescovitz; B Aasted; A Canals; J Dominguez; J S Vizcaino; R Pospisil; J Sinkora; H Salmon; I Valpotic; W C Davis
Journal:  Vet Immunol Immunopathol       Date:  1994-10       Impact factor: 2.046

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Membrane cofactor protein of the complement system. A HindIII restriction fragment length polymorphism that correlates with the expression polymorphism.

Authors:  N S Bora; T W Post; J P Atkinson
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

5.  Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes.

Authors:  T Seya; L L Ballard; N S Bora; V Kumar; W Cui; J P Atkinson
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

6.  Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP).

Authors:  C W van den Berg; J M Pérez de la Lastra; D Llanes; B P Morgan
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

7.  Molecular cloning of guinea pig membrane cofactor protein: preferential expression in testis.

Authors:  M Hosokawa; M Nonaka; N Okada; M Nonaka; H Okada
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

8.  Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies.

Authors:  T Hara; A Kojima; H Fukuda; T Masaoka; Y Fukumori; M Matsumoto; T Seya
Journal:  Br J Haematol       Date:  1992-10       Impact factor: 6.998

9.  Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury.

Authors:  K R McCurry; D L Kooyman; C G Alvarado; A H Cotterell; M J Martin; J S Logan; J L Platt
Journal:  Nat Med       Date:  1995-05       Impact factor: 53.440

10.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  4 in total

1.  Design and synthesis of an antigenic mimic of the Ebola glycoprotein.

Authors:  Ryan D Rutledge; Brian J Huffman; David E Cliffel; David W Wright
Journal:  J Mater Res       Date:  2008       Impact factor: 3.089

2.  Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.

Authors:  N A Begum; Y Murakami; S Mikata; M Matsumoto; M Hatanaka; S Nagasawa; T Kinoshita; T Seya
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

3.  Development of Improved Double-Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in Peripheral Blood Mononuclear Cells of Diabetic Patients and the Prefrontal Cortex of Multiple Sclerosis Patients.

Authors:  Dongyang Li; Christophe Morisseau; Cindy B McReynolds; Thomas Duflot; Jérémy Bellien; Rashed M Nagra; Ameer Y Taha; Bruce D Hammock
Journal:  Anal Chem       Date:  2020-04-27       Impact factor: 6.986

4.  Distribution of membrane cofactor protein (MCP/CD46) on pig tissues. Relevance To xenotransplantation.

Authors:  J M Pérez de la Lastra; S M Hanna; B P Morgan
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.